CIK 0001873835 · <br>Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454869378
- Phone
- (888) 958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and Chairman bought 2,178 shares at $2.30 ($4,999)
- 4 Open-market buy CFO bought 2,225 shares at $2.28 ($5,071)
- 4 Open-market buy Director bought 47,700 shares at an average $2.19 ($104,358)
- 4 Open-market buy Director bought 23,100 shares at an average $2.23 ($51,623)
- 4 Open-market buy Director bought 10,000 shares at $1.86 ($18,600)
- 4 Open-market buy Director bought 9,200 shares at an average $2.12 ($19,517)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CFO bought 2,500 shares at $2.12 ($5,298)
- 4 Open-market buy CEO and Chairman bought 2,600 shares at $2.13 ($5,538)
- 4 Open-market buy CFO bought 3,300 shares at $1.81 ($5,973)
Page 2 of 5 · 96 filings